Model-informed Precision Dosing for Linezolid

Clinical trial NCT06444802 · UNKNOWN

Trial details

NCT number: NCT06444802
Sponsor: University of Hamburg-Eppendorf
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Gram-Positive Bacterial Infections

Start date: 2024-09-01
Primary completion: 2026-02-28
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.